Notably, nitrogen-derived post-translational modifications (PTMs) of CCL2 drastically affect tumour homing of CD8+ T lymphocytes, while in contrast, nitrated/nitrosylated CCL2 does not lose the ability to engage MDSCs in the TME [171]. The gene discussed is CCL2; the disease is neoplasm.